A biochemist wants to control the initial substrate-level phosphorylation that occurs in the tracheal cells of grasshoppers once glucose has crossed the plasma membrane. He has access to the following inhibitors: Rotenone - an electron transport chain inhibitor, Oligomycin - an ATP synthase inhibitor, and TLN-232, an inhibitor of glycolysis. Which inhibitor should he use to slow down initial substrate-level phosphorylation that occurs once glucose has crossed the plasma membrane?
A. Rotenone
B. TLN-232
C. Oligomycin
D. None of these inhibitors would be effective in preventing substrate-level phosphorylation
Answer: B
You might also like to view...
A person who has a constant need to eat may show impaired secretion of or response to
A. growth hormone B. insulin C. thyroid hormone D. leptin E. thyroid-stimulating hormone
Which type of drug may interfere with the beneficial effects of a fever?
1.antibiotics 2.pain killers 3.aspirin 4.antidepressants 5.muscle relaxants
Bony fishes include all of the following EXCEPT _______.
a) lungfishes b) ray-finned fishes c) sharks d) coelacanths
Compared to the numbers of grasshoppers or deer, there are few mountain lions. The reason that large and fierce animals, such as the mountain lion, are rare in an ecosystem is that
Select one: a. such animals do not tolerate other members like them. b. through evolution, most fierce animals have been killed off by others. c. food chains are only 10-20% efficient at each step and top carnivores require large amounts of calories for their survival. d. only a few such animals are permitted by succession in a biome and there are only a few biomes. e. more large predators bring more disease to an ecosystem.